AVITA Medical (RCEL) Depreciation & Amortization (CF) (2019 - 2025)
AVITA Medical filings provide 7 years of Depreciation & Amortization (CF) readings, the most recent being $700000.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) rose 71.15% to $700000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 108.44% increase, with the full-year FY2025 number at $2.3 million, up 108.44% from a year prior.
- Depreciation & Amortization (CF) hit $700000.0 in Q4 2025 for AVITA Medical, up from $574000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $700000.0 in Q4 2025 to a low of $130000.0 in Q3 2022.
- Median Depreciation & Amortization (CF) over the past 5 years was $195000.0 (2023), compared with a mean of $289555.6.
- Biggest five-year swings in Depreciation & Amortization (CF): fell 25.29% in 2022 and later skyrocketed 170.59% in 2025.
- AVITA Medical's Depreciation & Amortization (CF) stood at $174000.0 in 2021, then fell by 25.29% to $130000.0 in 2022, then soared by 43.85% to $187000.0 in 2023, then surged by 118.72% to $409000.0 in 2024, then soared by 71.15% to $700000.0 in 2025.
- The last three reported values for Depreciation & Amortization (CF) were $700000.0 (Q4 2025), $574000.0 (Q3 2025), and $552000.0 (Q2 2025) per Business Quant data.